Leveraging electronic medical record (EMR) changes and virtual care towards improving tobacco screening and referral rates.

Authors

Lawson Eng

Lawson Eng

Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

Lawson Eng , Jennifer Do , Monica Ku , Naa Kwarley Quartey , Iryna Tymoshyk , Anna Feng , Yunlong Liang , Anjie Yang , Meredith Elana Giuliani , Suman Dhanju , Colleen Dunphy

Organizations

Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada, Princess Margaret Cancer Centre, Toronto, ON, Canada, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Department of Pharmacy, University Health Network, Toronto, ON, Canada

Research Funding

Ontario Health - Cancer Care Ontario

Background: Continued smoking after a cancer diagnosis is associated with poorer outcomes. Ontario Regional Cancer Centres are required to screen all new cancer patients for tobacco use and offer referrals for cessation support to patients using tobacco. At Princess Margaret Cancer Centre (Toronto, Canada), we leveraged an EMR change to Epic along with uptake in virtual care strategies from COVID-19, to improve both tobacco screening and referral rates for new patients. Methods: Following the EMR transition to Epic in June 2022, we piloted EMR and virtual care strategies from Jan 2023 to Mar 2024 to improve both tobacco screening and referral rates. Due to precautions during COVID-19, screening and referrals were completed using a hybrid pre-visit electronic tobacco use assessment questionnaire and in clinic paper-based referral system. Our interventions were co-developed by a team of hospital leadership, IT team members and clinicians. These included: 1) Collation of tobacco assessment data sources on Epic (Jan 2023); 2) Creation of an Epic referral inbox to track referrals (Aug 2023); 3) Assignment of electronic pre-visit tobacco assessments questionnaires to correct visit types (Sep 2023); 4) Creation of a half-day virtual nursing clinic to offer referrals for cessation support to patients initially declining support or those who were not offered using monthly reports from Epic (Nov 2023). Screening and referral rates were tracked monthly and quarterly during this period. Results: From Jan 2023 to March 2024, 15,063 new patients presented to our cancer centre. Baseline screening and referral rates before COVID-19 were 47% and 16%, respectively. Prior to this QI initiative, screening and referral rates were 18% and 1%, respectively. Post implementation, screening and referral rates improved to 42% and 25% (Table); rates of current tobacco use remained consistent from 12-16%. Collation of tobacco use assessments data on Epic had the greatest impact on improving screening rates from 18% to 39% (p<0.001), while the virtual nursing clinic helped to improve referral rates from 3% to 25% (p<0.001), with the greatest referral rate in Jan 2024 at 36%. Our virtual nursing clinic was feasible, where among patients contacted who initially declined or were not offered cessation support, 90% were contacted within 1-3 phone calls. Among patients contacted, 20% accepted a referral, while 41% of patients had already quit smoking by the time of contact. Conclusions: Both EMR and virtual care strategies helped to successfully improve both tobacco screening and referral rates for smoking cessation support; with the greatest impact from the collation of EMR data sources on tobacco use and development of a virtual nurse led clinic.

Quarterly tobacco screening and referral rates.

Jan-Mar 2023Apr-Jun 2023Jul-Sep 2023Oct-Dec 2023Jan-Mar 2024
Screening33%38%39%41%42%
Referrals0%1%3%20%25%

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship

Sub Track

Use of IT/Analytics to Improve Quality

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 426)

DOI

10.1200/OP.2024.20.10_suppl.426

Abstract #

426

Poster Bd #

H2

Abstract Disclosures

Similar Abstracts

First Author: Thulasee Jose

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center.

First Author: Christian Adams-Carey

First Author: Dalia Littman

Abstract

2021 ASCO Annual Meeting

Trends in cancer screening volumes at an urban health center during the COVID-19 pandemic.

First Author: Mahir Khan